Hydrochlorothiazide Tablet
Product Images NDC 51655-422

3 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 51655-422). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hydrochlorothiazide (1e92de42 A7f2 4674 8260 28cfabf0759d 01)

Hydrochlorothiazide (1e92de42 A7f2 4674 8260 28cfabf0759d 01)
Chemical structure of Hydrochlorothiazide showing a chlorinated benzene ring fused with a heterocyclic sulfonamide ring, with molecular formula C7H8ClN3O4S2 and molecular weight 297.74.*
FDA Label Image

Company Logo (1e92de42 A7f2 4674 8260 28cfabf0759d 02)

FDA Label Image

Label (51655 422 52 Rev A 06 23 Nhc)

Label (51655 422 52   Rev A 06 23 Nhc)
Hydrochlorothiazide Tablets USP 50 mg oral tablets, packaged in a container of 30 tablets. The label specifies storage instructions, dosage directions to see the package insert, and includes manufacturer information for Northwind Health Company, LLC. The product NDC is 51655-422.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.